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AbstrAct
Introduction Sleep and mental health go hand-in-hand, 
with many, if not all, mental health problems being 
associated with problems sleeping. Although sleep 
has been traditionally conceptualised as a secondary 
consequence of mental health problems, contemporary 
views prescribe a more influential, causal role of sleep in 
the formation and maintenance of mental health problems. 
One way to evaluate this assertion is to examine the extent 
to which interventions that improve sleep also improve 
mental health.
Method and analysis Randomised controlled trials 
(RCTs) describing the effects of interventions designed 
to improve sleep on mental health will be identified via 
a systematic search of four bibliographic databases (in 
addition to a search for unpublished literature). Hedges’ 
g and associated 95% CIs will be computed from means 
and SDs where possible. Following this, meta-analysis will 
be used to synthesise the effect sizes from the primary 
studies and investigate the impact of variables that could 
potentially moderate the effects. The Jadad scale for 
reporting RCTs will be used to assess study quality and 
publication bias will be assessed via visual inspection of a 
funnel plot and Egger’s test alongside Orwin’s fail-safe n. 
Finally, mediation analysis will be used to investigate the 
extent to which changes in outcomes relating to mental 
health can be attributed to changes in sleep quality.
Ethics and dissemination This study requires no ethical 
approval. The findings will be submitted for publication 
in a peer-reviewed journal and promoted to relevant 
stakeholders.
PrOsPErO registration number CRD42017055450.
IntrOductIOn
Difficulties sleeping and mental health prob-
lems are both public health concerns in their 
own right, with each having a substantive 
impact on both individuals and society as a 
whole.1–4 However, sleep and mental health 
go hand-in-hand, with many, if not all, mental 
health problems being associated with prob-
lems sleeping.5–7 Traditionally, sleep prob-
lems have been viewed as a consequence of 
mental health problems. Although this is 
not contested, evidence also suggests that 
problems sleeping can contribute to the 
formation of new mental health problems8–10 
and to the maintenance of existing ones.11–13 
In other words, sleep is now thought to have a 
bidirectional relationship with mental health, 
with problems sleeping likely to influence 
both the onset and trajectory of a variety of 
mental health difficulties. Having said this, 
although a number of empirical studies have 
manipulated sleep and examined the impact 
of doing so on outcomes related to mental 
health, to date there has not been a system-
atic review of these studies. Consequently, 
the magnitude of the effect of (changes in) 
sleep on mental health problems is diffi-
cult to estimate and has not been compared 
between different mental health outcomes 
and other factors that might influence the 
effect (eg, across different groups of partic-
ipants, research designs and approaches to 
intervention).
The potential for a causal relationship 
between sleep and mental health also raises 
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Protocol
strengths and limitations of this study
 ► The proposed review should provide reliable 
evidence on the effect of interventions designed to 
improve sleep on outcomes reflecting mental health.
 ► The findings of the proposed review will further 
elucidate the nature of the relationship between 
sleep and mental health.
 ► The GRADE (Grading of Recommendations, 
Assessment, Development and Evaluation) system 
will be used to assess the strength of the evidence 
base and allow members of the public, researchers 
and clinicians to judge the quality of the available 
evidence.
 ► The proposed review will include a diverse range 
of interventions and target problems and so might 
lead to a heterogeneous group of studies. However, 
to mitigate this, moderation analysis will be used to 
investigate specific factors that might influence the 
effect of sleep improvement on mental health.
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an exciting prospect; namely, that interventions designed 
to improve sleep could also improve mental health. 
Providing a definitive answer to this question would have 
important implications for clinicians, researchers and 
members of the public alike. From a practical perspective, 
if interventions designed to improve sleep can change 
mental health outcomes, then they may be a useful tool 
for tackling mental health difficulties. Indeed, interven-
tions designed to improve sleep can often be delivered 
remotely, in self-help and group formats, and/or at little 
cost through the internet.14–18 For example, a meta-anal-
ysis by Ho et al reported that self-help interventions based 
on the principles of cognitive behavioural theory (CBT) 
for insomnia (termed CBTi) had medium to large effects 
on the symptoms of insomnia.18
current evidence on the relationship between sleep and 
mental health
The relationship between sleep and mental health is 
well documented, with numerous reviews testifying to a 
robust link between the two.6–8 19–24 However, the majority 
of these reviews have focused on primary studies with 
correlational research designs. That is, they (1) measure 
associations between variables at a single time point 
(ie, cross-sectional designs); (2) measure associations 
between variables at multiple time points (ie, longitudinal 
designs) or (3) compare the typical sleep profiles of those 
with mental health difficulties to those without.6 7 25 26 
Unfortunately, cross-sectional designs simply tell us that 
variables are associated in some way. It is impossible to 
determine whether sleep causes mental health problems, 
mental health problems cause difficulties in sleeping or 
whether the effect is bidirectional in nature.
Longitudinal studies, although still correlational in 
nature, are better able to elucidate causality than their 
cross-sectional counterparts. However, only a handful 
of reviews have provided evidence on the relationship 
between sleep (at one point in time) and mental health 
outcomes (measured later). Furthermore, all of these 
have focused on depression.8 24 27 28 For example, Baglioni 
et al8 meta-analysed 21 studies that investigated the longi-
tudinal associations between insomnia and depression. 
Baglioni et al reported that people with insomnia had 
a twofold risk of developing depression compared with 
people who did not experience difficulties in sleeping. 
Longitudinal designs are also still susceptible to the ‘third 
variable problem’.29–31 Namely, that a third, unmeasured 
variable (eg, having young children) could cause both 
sleep difficulties and mental health problems. In summary, 
correlational designs are not a valid way of disentangling 
the relationship between problems sleeping and mental 
health.
Some reviews have assessed the impact of interven-
tions designed to improve sleep on mental health 
outcomes.17 18 23 24 32–36 However, for a number of reasons, 
even these reviews do not permit us to draw robust 
conclusions as to the causal impact of sleep quality on 
mental health outcomes. First, these reviews often include 
interventions that have not successfully manipulated 
sleep (ie, studies in which there was no significant impact 
of the intervention on sleep outcomes). Such studies 
do not tell us anything about the relationship between 
sleep and mental health other than that it can be diffi-
cult to improve sleep. Second, the focus of extant reviews 
has been on improving sleep, with the measurement of 
mental health outcomes being secondary and typically 
limited to depression and anxiety. Consequently, the 
effect of improving sleep on other mental health prob-
lems is currently unclear.
Finally, to our knowledge, to date there has been 
no attempt to investigate variables that influence—or 
moderate—the impact of interventions that improve 
sleep on mental health. However, interventions designed 
to improve sleep are likely to vary in their content and 
delivery, and such variables may influence how effec-
tive they are (or appear to be) in improving sleep and/
or mental health outcomes. Furthermore, variables 
related to the nature of the sample (eg, age, severity of 
symptoms, nature of the mental health problem) and 
methodological features of the study (eg, self-report vs 
objective assessment of the outcome variables) are likely 
to influence the apparent effect of the intervention. It 
is therefore crucial that the impact of such variables is 
systematically examined across the extant evidence base 
in order to draw reliable and valid conclusions about the 
impact of changes in sleep on outcomes pertaining to 
mental health.
the proposed review
A number of primary research studies have experimen-
tally manipulated sleep (typically via some sort of psycho-
logical intervention) and then measured mental health 
outcomes. However, as described above, these individual 
studies have, to our knowledge, never been integrated 
in a manner that allows the magnitude of the effect 
of sleep quality on mental health outcomes to be esti-
mated. Therefore, it is currently difficult to: (1) draw 
firm conclusions about the relationship between sleep 
and various mental health problems and (2) recommend 
with any confidence that mental health problems might 
be tackled using interventions that have been designed 
to improve sleep. Furthermore, to date there has been 
no attempt to understand the factors that influence, or 
moderate, the effect of improvements in sleep on mental 
health. As a consequence, it is currently unclear whether 
and how the content and nature of the intervention(s), 
target sample and mental health problem, and meth-
odological features of the primary study influence the 
effects of interventions designed to improve sleep on 
mental health outcomes.
Objectives
The proposed review therefore has two broad objectives: 
(1) to synthesise and quantify the effect of interventions 
that improve sleep on outcomes reflecting mental health 
and (2) to explore variables that moderate the effect 
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of interventions targeting sleep on outcomes reflecting 
mental health.
MEthOd And AnAlysIs
This protocol has been prepared in accordance with the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses Protocol (PRISMA-P, see online supple-
mentary material 1) checklist.37
Outcomes and prioritisation
Measuring improvements in sleep
The concept of ‘improved sleep’ is multifaceted and can 
mean different things to different people.38–40 Indeed, 
many specific sleep problems are tied to mental health in 
unique ways and often have their own unique measures. 
For example, the experience of nightmares has been 
found to be associated with post-traumatic stress disorder 
(PTSD),41 as measured using specific outcome measures 
such as dream diaries42 43 or the Clinician-Adminis-
tered PTSD Scale.44 Consequently, one challenge for 
the proposed review is to ensure that all of the primary 
studies assess a similar notion of sleep improvement. To 
achieve this, the proposed review will require that the 
primary studies report a measure that reflects the overall 
quality of sleep experienced by participants. Broadly 
speaking, sleep quality consists of: (1) sleep continuity 
(eg, sleep onset, sleep maintenance and number of awak-
enings) and (2) daytime impact (eg, the extent to which 
the person feels refreshed on waking and throughout the 
day).39 40
Sleep quality can be measured using both self-report 
and objective indices. For example, the Pittsburgh Sleep 
Quality Index45 is widely recognised as the ‘gold stan-
dard’ self-report measure of sleep quality and consists 
of 19 items measuring seven aspects of sleep quality 
(namely, subjective sleep quality, sleep latency, sleep 
duration, sleep efficiency, sleep disturbances, use of sleep 
medication and daytime dysfunction). The ‘gold stan-
dard’ for objectively measuring sleep is accepted to be 
polysomnography46; a technique that monitors multiple 
biophysiological parameters and directly records aspects 
of sleep quality including sleep onset and sleep main-
tenance (for a review, see Vaughn and Giallanza47). As 
such, the proposed review will include both self-report 
and objective indices of sleep quality, but will also seek 
to compare effect sizes between different measures in 
an effort to empirically examine the extent to which the 
nature of the measures influences the apparent effect of 
the interventions.
Measuring mental health
Measuring mental health is also complex and multifac-
eted, with a range of different outcomes which differ both 
in their administration and interpretation. Some studies 
will report a general measure assessing a specific diag-
nostic category (eg, a measure of the severity of depres-
sion). For example, the Beck Depression Inventory II is 
a 21-item self-report measure designed to assess multiple 
facets of depression including mood, pessimism, self-dis-
like, loss of appetite and social withdrawal, with higher 
scores indicating more severe depression.48 Other studies 
might assess a single symptom or problem. For example, 
the Green Paranoid Thoughts Scale measures paranoid 
thoughts,49 an experience that is associated with, but is not 
limited to, psychosis spectrum disorders.50 51 Finally, some 
studies may report the effects of interventions designed 
to improve sleep on global measures of mental health. 
For example, the Clinical Global Impressions Severity 
scale52 asks clinicians to use their clinical experience to 
rate how mentally ill their client has been over the last 
week, on a scale ranging from 1—normal to 7—among 
the most extremely ill patients.
Measures assessing aspects of mental health can either 
be: (1) self-reported by the participant or (2) completed 
on behalf of the participant by a clinician or other inde-
pendent rater. Both self-report and independently rated 
outcome measures will be included in the proposed 
review; however, as above, we will compare effect sizes 
between different measures in an effort to empirically 
examine the extent to which the nature of the measure(s) 
influences the apparent effect of the interventions.
Eligibility criteria
Inclusion criteria
In order to be included in the proposed review, the 
primary studies need to:
1. Randomly allocate participants to either an 
experimental group that receives an intervention that 
is designed to improve sleep or a comparison group.
2. Report a statistically significant improvement on 
a measure of sleep quality in at least one follow-up 
point among participants in the experimental group 
as compared with those in the comparison group.
3. Include a measure of mental health subsequent to the 
measure of sleep quality.
4. Report sufficient data for us to be able to compute 
effect sizes reflecting the impact of the intervention 
on (1) sleep quality and (2) mental health. Where 
sufficient data is not reported, we will contact the au-
thors and request further data. However, if this is not 
provided, then the study will not be included in the 
review.
5. Be written in English or be able to be translated using 
available translation resources.
Exclusion criteria
The aim of the proposed review is to be as inclusive as 
possible and address potential differences between 
the primary studies (eg, differences in the nature of 
the intervention or the mental health problem under 
consideration) using moderation analysis. Therefore, we 
will not restrict the type of intervention (eg, psycholog-
ical and pharmacological), publication status, nature of 
the comparison condition or sample (ie, interventions 
directed towards adults, children and adolescents will all 
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Table 1 Search terms that will be used to identify RCTs 
of interventions designed to improve sleep on outcomes 
pertaining to mental health
HSSS for RCTs† Sleep Mental health
Randomized 
controlled trial
Sleep* “Psychological health”
Controlled clinical 
trial
“Circadian 
rhythm*”
“Mental”
Randomized Insomnia Psychiat*
Placebo Hypersomnia Affect*
Drug therapy Parasomnia Depress*
Randomly Narcolepsy Mood
Trial Apnea Stress
Groups Apnoea Anxi*
  Nightmare* Phobi*
  “Restless legs 
syndrome”
“Obsessive compulsive 
disorder”
  OCD
  PTSD
  “Post-traumatic stress 
disorder”
  Psychos*
  Psychotic
  Schiz*
  Bipolar
  Hallucination*
  Delusion*
  “Eating disturbance*”
  Anorexia
  Bulimia
  “Binge eating”
Studies will need to include at least one search term from each of 
the filter above in the title, abstract or keywords, for consideration 
for inclusion in the review.* indicates that variants of the word 
after the asterisk will be searched for (eg, depress* will search for 
depressive, etc)
 †The highly sensitive search strategy (HSSS) is more than just a 
keyword search, rather it encompasses search techniques and 
strategies.53
OCD, obsessive compulsive disorder; PTSD, post-traumatic stress 
disorder; RCT, randomised controlled trial.
be eligible). However, in order to ensure that we can reli-
ably and validly assess the independent contribution of 
changes in sleep on mental health outcomes among adult 
populations, studies with the following characteristics will 
be excluded:
1. Studies where the intervention contains elements that 
specifically target a mental health problem alongside 
improving sleep (eg, an intervention that provides 
CBT for anxiety alongside efforts to improve sleep).
2. Studies that recruit children and young people (ie, 
under the age of 18 years old).
3. Studies adopting a pre-post design (ie, within 
participant designs).
Information sources
The proposed review will use a combination of search 
techniques and sources in order to identify potential 
studies. First, we will search MEDLINE (1946 to present), 
Embase (1974 to present), PsycINFO (1967 to present) 
and The Cochrane Library (1898 to present) using the 
Cochrane Highly Sensitive Search Strategy53 to identify 
RCTs that include terms relating to sleep quality and/or 
sleep disorders and mental health (see table 1 for a list 
of the proposed search terms). The search strategy has 
been developed in collaboration with a health sciences 
librarian specialising in systematic search procedures and 
will be used to search each database (see online supple-
mentary material 2 for an example search strategy). 
Second, the reference lists of extant reviews of the rela-
tionship between sleep and mental health (eg, those cited 
in the introduction) will be searched for any potential 
articles. Third, a search for any unpublished or ongoing 
studies will be conducted by searching online databases 
including White Rose Online, The National Research 
Register, WHO approved clinical trial databases (eg, 
ISRCTN) and PROSPERO. Finally, the authors of articles 
deemed eligible for inclusion will be contacted and asked 
if they are aware of any unpublished research that may be 
eligible for inclusion in the review.
data management
All records will be stored in the reference management 
software Endnote, and we will follow PRISMA guidelines 
for the selection of studies for meta-analysis.54 Specifi-
cally, when the pool of potential studies has been iden-
tified, we will remove duplicates and initially screen each 
record based on the title and abstract and exclude clearly 
ineligible studies. Following this initial screening, the 
full-text versions of each article will be reviewed in detail 
and cross-referenced against the inclusion and exclusion 
criteria. The flow of articles through the review, including 
the reasons for excluding studies, will be documented in 
a PRISMA flow chart.
data extraction
Data will be recorded on a standardised data extraction 
form and a manual will accompany this form and detail 
each variable to be extracted alongside definitions and 
examples (see online supplementary materials 3 and 4). 
Two reviewers will pilot the data extraction forms and 
manual on three articles in order to ensure that there are 
no systematic problems or difficulties in coding any of the 
variables. After this, the data will be extracted from the 
full set of studies by one reviewer. A second member of 
the review team will second code a subset of the included 
articles (at least 10%) and levels of agreement will be 
calculated (the subset of articles for second coding will 
be randomly selected using a computer generated algo-
rithm). Any disagreements will be resolved through 
discussion, with a third member of the review team acting 
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Table 2 Variables to be extracted for moderation analysis (where available, see supplementary material 3 for detailed variable 
categories and levels)
Source 
characteristics Sample characteristics Design characteristics Intervention characteristics
Publication status Age Method of recruitment Size of the effect on sleep
Publication year Gender Nature of comparison group(s) Duration
Journal impact factor Type of mental health problem(s) Attrition/dropout rate Theoretical basis
  Type of sleep problem(s) Timing of follow-up Mode of delivery
  Clinical status of mental health Nature of outcome measure(s) Adherence
  Clinical status of sleep problem Type of analysis
  Comorbidity Adjusted versus unadjusted data
  Concurrent medication use Study quality
  Concurrent psychological help
as an arbiter for any outstanding disagreements. The 
review team will extract meta-data pertaining to source 
characteristics (eg, publication status and year), as well as 
data relating to the characteristics of the sample (eg, age, 
type of mental health problem), the study (eg, the nature 
of the comparison group, length of follow-up) and char-
acteristics of the intervention (eg, theoretical basis, mode 
of delivery). Table 2 provides an overview of the poten-
tial moderators that we propose to code and examine, 
and online supplementary material 3 provides detail on 
specific moderator levels and categories.
Proposed analysis
Review Manager V.5.3 (Cochrane Collaboration)55 will 
be used to compute Hedges’ g (and associated 95% 
CIs) using the means and standard deviations for each 
measure of sleep quality and mental health reported in 
studies comparing these outcomes between an interven-
tion group (ie, a group receiving an intervention that 
improves sleep) and a comparison group (eg, wait-list, 
placebo, treatment as usual)i. Where means and stan-
dard deviations are not available, we will compute effect 
sizes by converting relevant summary statistics (eg, F values 
from an analysis of variance, testing the impact of an 
intervention on relevant outcomes) using Lyons Morris’ 
meta-analysis calculator.56 The effect of the interventions 
on sleep quality will be assessed using data from the first 
available follow-up point that reports a statistically signifi-
cant difference in sleep quality between the intervention 
and comparison conditions. The effect of the interven-
tions on outcomes pertaining to mental health will be 
i Wherever available, data that have been adjusted for baseline differ-
ences between groups will be used to compute effect sizes. However, if 
this information is not reported then we will use the unadjusted data 
to compute the effect sizes. We will also seek to compute effect sizes 
using the data from intention-to-treat (ITT) analyses where they are 
reported. Subscripts will be added to the table reporting the effect sizes 
derived from the primary research studies in order to identify how each 
effect size was computed and also to compare outcomes between studies 
that report adjusted versus unadjusted statistics and ITT analyses versus 
non-ITT analyses.
assessed at the longest follow-up point available, whether 
the effect at this point is statistically significant or not 
(and we will investigate the effect of follow-up duration 
on outcomes using moderation analysis). This strategy 
will provide a stringent test of the effect of the interven-
tions on outcomes pertaining to mental health (in the 
sense that any changes need to have been maintained 
over time) and also enable us to investigate whether the 
impact of the interventions on outcomes is mediated 
by changes in sleep quality that precede the impact on 
outcomes pertaining to mental health (this proposed 
analysis is discussed in the 'mediation analysis' section).
Where studies report multiple outcome measures under 
one diagnostic category (eg, several measures of depres-
sion or sleep quality), the effect sizes will be computed 
for each outcome and meta-analysed in their own right 
to form one overall effect for inclusion in the main anal-
ysis. For example, we would compute two effect sizes 
reflecting sleep quality if a study reported the effects of an 
intervention on the Pittsburgh Sleep Quality Index45 and 
the Insomnia Severity Index57 (ie, one effect size for each 
measure of sleep quality) and then average them before 
inclusion in the main dataset. This procedure capital-
ises on the information that is available, while retaining 
the independence of effect sizes which is central to the 
validity of meta-analysis.58
The sample-weighted average effect size (g+) will be 
computed using a random effects model as studies are 
likely to be ‘different from one another in ways too 
complex to capture by a few simple study characteris-
tics’.59 Following Cohen’s60 recommendations, g=0.20 will 
be taken to represent a ‘small’ effect size, g=0.50 a 
‘medium’ effect size and g=0.80 a ‘large’ effect size. We 
will use these qualitative indices to interpret the findings. 
Publication bias will be assessed via visual inspection of a 
funnel plot and Egger’s test.61 Finally, Orwin’s62 formula 
will be used to determine the fail-safe n (ie, the number 
of studies producing a null effect that would be needed 
to reduce the overall effect of interventions that improve 
sleep on outcomes relating to mental health to a trivial 
effect size).
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heterogeneity, bias and study quality
The I2 statistic will be used to assess the heterogeneity of 
effect sizes across the primary studies.63 The quality of 
each individual study included in the proposed review 
will be assessed using the Jadad scale for reporting 
RCTs.64 The Jadad scale assesses three key areas of meth-
odological quality that potentially lead to bias—namely, 
randomisation, blinding and the flow of participants 
through the study. In order to assess these areas, raters 
will be asked to answer three questions: (1) ‘Was the study 
described as randomized (ie, does it include words such 
as randomly, random, and randomization)?’; (2) ‘Was the 
study described as double blind?’; and (3) ‘Was there a 
description of withdrawals and dropouts?’. Scores on the 
Jadad scale range from 0 to 5, with higher scores indi-
cating a lower risk of bias (and therefore higher method-
ological quality). The Jadad scale for reporting RCTs has 
been extensively used as a measure of the methodological 
quality of RCTs (having received over 7500 citations to 
date) and has been recommended as the most reliable 
and valid scale for assessing the quality of RCTs in a review 
of 21 measures.65 Finally, the Grading of Recommenda-
tions, Assessment, Development and Evaluation (GRADE) 
system66 67 will be used to assess the quality of the body of 
evidence as a whole and the extent to which it can and 
should be used to inform clinical recommendations.
Moderation analysis
Moderation analyses will be used to identify variables that 
influence the effect of interventions that improve sleep 
on both mental health. Many of these variables and their 
subcategories are outlined in table 2 (for more detail see 
online supplementary material 3); however, we are keen 
to be flexible and responsive to the literature as the search 
develops. Imposing an exhaustive coding structure a priori 
without knowledge of the primary studies included in the 
review may result in an unsuitable structure that does 
not accurately reflect the nature of the included studies. 
Consequently, table 2/online supplementary material 3 is 
not intended to provide an exhaustive list of moderators 
and we are open to considering additional moderators 
and categories as the search and data extraction develops. 
However, in order to ensure that the reader is clear on 
what analyses were preplanned, we will label any analyses 
that are not prespecified in this protocol as exploratory in 
the final report. Moderation analysis will be undertaken 
to explore the effect of variables relating to the nature of 
the focal sample, the methodological design and inter-
vention characteristics across all studies within the main 
meta-analyses.
We will require a minimum of k=3 studies representing 
each moderator level category in order to conduct 
moderation analysis (eg, to investigate the effect of 
outcome type on effect sizes, we will require data from 
at least three studies using self-report outcomes and at 
least three studies using clinician completed outcomes). 
For continuous moderators (eg, age, publication year, 
study quality), sample weighted meta-regression will be 
used to investigate the impact of the moderator on effect 
sizes. For example, the quality of a given study, assessed 
using the Jadad scale,64 will be used as the independent 
variable in a sample-weighted meta-regression, with the 
effect sizes representing the effect of the interventions on 
outcomes pertaining to mental health used as the depen-
dent variable. For categorical variables (eg, self-report vs 
clinician rated outcomes, the nature of the comparison 
condition), the sample-weighted average effect size (g+) 
and associated standard errors will be computed for each 
level of the moderator and then the Q statistic will be used 
to assess if the effect sizes are significantly different. For 
example, effect sizes based on clinician rated measures 
of mental health (eg, the Clinical Global Impressions 
Severity Scale52) will be compared with effect sizes based 
on self-report measures of mental health (eg, the Depres-
sion, Anxiety and Stress Scale68).
Mediation analysis
Mediation analysis will be used to investigate the extent 
to which changes in mental health can be attributed to 
changes in sleep. These analyses will include all studies 
that report the correlation between (changes in) sleep 
quality and (changes in) mental health outcomes (the 
correlation between the intervention and sleep quality and 
mental health outcomes, respectively, will be computed 
by converting the sample-weighted average effect of the 
interventions on these outcomes into effect size r). These 
(sample-weighted, average) correlations will be entered 
using the matrix function into SPSS (version 23) to permit 
analysis as if they resulted from a primary dataset. In line 
with Kenny, Kashy and Bolger’s69 recommendations, we 
will then conduct four multiple regressions in order to 
investigate mediation. These regressions will test: (1) 
the effect of the independent variable (ie, the interven-
tion) on the dependent variable (ie, outcomes reflecting 
mental health); (2) the effect of the independent vari-
able on the putative mediator (ie, outcomes reflecting 
sleep quality); (3) the effect of the mediating variable on 
the dependent variable and (4) the simultaneous effect 
of the independent variable and the mediator on the 
dependent variable, respectively. If the effect of the inter-
ventions on mental health can be attributed to changes 
in the quality of sleep, then the impact of the interven-
tions on outcomes pertaining to mental health should be 
significantly reduced when the effect of the interventions 
on sleep quality is statistically controlled.
Ethics and dissemination
As the proposed research is a meta-analytic review of 
primary studies, no ethical approval is required. We 
have registered the proposed review on the PROSPERO 
database (CRD42017055450) in order to adhere to the 
principles of open research. Following completion of the 
review, we will submit the findings for publication in a 
peer-reviewed academic journal and attend conferences 
and dissemination events with stakeholders wherever 
possible.
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dIscussIOn
The proposed review will use meta-analysis alongside 
moderator and (meta)mediation analyses to (1) quantify 
the effect of interventions that improve sleep on mental 
health outcomes, (2) test whether any effect of the inter-
ventions on these outcomes is mediated by changes in 
sleep quality and (3) explore variables that potentially 
moderate the effect of the interventions targeting sleep 
on mental health outcomes. The proposed review has a 
number of strengths that we believe will make a substan-
tive contribution. First, the review will be inclusive and 
investigate the effect of improving sleep on a wide range 
of mental health problems. Second, the review will 
further elucidate our understanding of the causal rela-
tionship between sleep and mental health by including 
only studies that successfully manipulate sleep and by 
conducting a mediation analysis to investigate whether 
any changes in mental health can be attributed to changes 
in sleep. Finally, the GRADE system will be used to assess 
the strength of the evidence base66 67 which should allow 
members of the public, researchers and clinicians to 
quickly access the available evidence and judge its quality.
Despite the strengths of the proposed review, however, 
the wide range of interventions and target problems that 
are likely to be addressed by the primary research studies 
may lead to a relatively heterogeneous group of studies 
(and thus, potentially effect sizes) which may lead to 
concerns that we are not comparing ‘like with like’ (cf. 
the problem of mixing apples and oranges70) and limit 
the extent to which the findings can be generalised to 
a specific population (eg, to those with depression). 
However, to mitigate these concerns we will use moder-
ation analysis to investigate specific factors that might 
influence the effect of improvements in sleep on mental 
health and to estimate the sample-weighted average effect 
sizes for different types of interventions and on different 
mental health outcomes. Our hope is that these anal-
yses prove informative, both in understanding mental 
health problems (ie, for which mental health problems 
can changes in sleep quality be expected to influence 
outcomes?) and in developing interventions designed to 
mitigate these problems (eg, the review will be able to 
identify which interventions are most effective).
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